Literature DB >> 17547100

Quality of HIV laboratory testing in Tanzania: a situation analysis.

G S Mfinanga1, B Mutayoba, G Mbogo, A Kahwa, G Kimaro, P P Mhame, C Mwangi, M N Malecela, A Y Kitua.   

Abstract

Tanzania is scaling up prevention, treatment, care and support of individuals affected with HIV. There is therefore a need for high quality and reliable HIV infection testing and AIDS staging. The objective of this study was to assess laboratories capacities of services in terms of HIV testing and quality control. A baseline survey was conducted from December 2004 to February 2005 in 12 laboratories which were conveniently selected to represent all the zones of Tanzania. The questionnaires comprised of questions on laboratory particulars, internal and external quality control for HIV testing and quality control of reagents. Source and level of customer satisfaction of HIV test kits supply was established. Of 12 laboratories, nine used rapid tests for screening and two used rapid tests for diagnosis. In the 12 laboratories, four used double ELISA and five used single ELISA and three did not use ELISA. Confirmatory tests observed were Western Blot in three laboratories, DNA PCR in two laboratories, CD4 counting in seven laboratories, and viral load in two laboratories. Although all laboratories conducted quality control (QC) of the HIV kits, only two laboratories had Standard Operating Procedures (SOPs). Internal and external quality control (EQC) was done at varied proportions with the highest frequency of 55.6% (5/9) for internal quality control (IQC) for rapid tests and EQC for ELISA, and the lowest frequency of 14.3% (1/ 7) for IQC for CD4 counting. None of the nine laboratories which conducted QC for reagents used for rapid tests and none of the five which performed IQC and EQC had SOPs. HIV kits were mainly procured by the Medical Store Department and most of laboratories were not satisfied with the delay in procurement procedures. Most of the laboratories used rapid tests only, while some used both rapid tests and ELISA method for HIV testing. In conclusion, the survey revealed inadequacy in Good Laboratory Practice and poor laboratory quality control process for HIV testing reagents, internal and external quality control.

Entities:  

Mesh:

Year:  2007        PMID: 17547100     DOI: 10.4314/thrb.v9i1.14291

Source DB:  PubMed          Journal:  Tanzan Health Res Bull        ISSN: 0856-6496


  4 in total

1.  Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania.

Authors:  Meghan K Mayhood; Isaac A Afwamba; Christopher O Odhiambo; Epimack Ndanu; Nathan M Thielman; Anne B Morrissey; John F Shao; Brian Wells Pence; John A Crump
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

2.  The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania.

Authors:  Leonard E G Mboera; Deus S Ishengoma; Andrew M Kilale; Isolide S Massawe; Acleus S M Rutta; Gibson B Kagaruki; Erasmus Kamugisha; Vito Baraka; Celine I Mandara; Godlisten S Materu; Stephen M Magesa
Journal:  BMC Health Serv Res       Date:  2015-06-26       Impact factor: 2.655

3.  Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania.

Authors:  Deus S Ishengoma; Mathias L Kamugisha; Acleus S M Rutta; Gibson B Kagaruki; Andrew M Kilale; Amos Kahwa; Erasmus Kamugisha; Vito Baraka; Celine I Mandara; Godlisten S Materu; Julius J Massaga; Stephen M Magesa; Martha M Lemnge; Leonard E G Mboera
Journal:  BMC Health Serv Res       Date:  2017-01-23       Impact factor: 2.655

4.  Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.

Authors:  Avelin F Aghokeng; Eitel Mpoudi-Ngole; Henriette Dimodi; Arrah Atem-Tambe; Marcel Tongo; Christelle Butel; Eric Delaporte; Martine Peeters
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.